# Linking Tau PET to Medial Temporal Lobe Subregions With High Resolution MRI

> **NCT04251130** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 150 (estimated)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** 2-(2-([18F]fluoro)pyridin-4-yl)-9H-pyrrolo[2,3-b:4,5-c']dipyridine

## Key facts

- **NCT ID:** NCT04251130
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-03-11
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04251130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04251130, "Linking Tau PET to Medial Temporal Lobe Subregions With High Resolution MRI". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04251130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*